AbbVie, Lennar and FedEx fall while Bausch Health rises

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

AbbVie Inc., down $12.75 to $65.70

The pharmaceutical company is buying Botox maker Allergan in a cash-and-stock deal valued at around $63 billion.

Bausch Health Companies Inc., up 62 cents to $24.38

The health care products company said it will pay down about $100 million worth of debt.

FedEx Corp., down $4.92 to $155.98

FedEx is suing the United States government over export rules it says are virtually impossible to follow because it handles millions of packages a day.

Lennar Corp., down $3.19 to $48.22

Tariff concerns and a disappointing third quarter outlook weighed on the homebuilder's stock.

The Medicines Co., down $1.60 to $33.76

The biotechnology company is issuing $150 million of its stock as it raises funds to develop a potential cholesterol drug.

Rambus Inc., down 5 cents to $11.50

Visa is buying the chipmaker's token services and ticketing businesses, according to media reports.

Bank of America Corp., down 22 cents to $27.76

The banking sector suffered as higher bond prices pushed yields lower, which means banks can charge less for loan interest.

Alphabet Inc., down $29.12 to $1,087.58

The parent of Google and other internet stocks fell as investors headed for less risky holdings.

Should you invest $1,000 in Lennar right now?

Before you consider Lennar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lennar wasn't on the list.

While Lennar currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: